Biology Reference
In-Depth Information
Peacock CS, Peterson J, Quail MA, Rabbinowitsch E, RajandreamMA, Reitter C, Salzberg SL,
Sanders M, Schobel S, Sharp S, Simmonds M, Simpson AJ, Tallon L, Turner CM, Tait A,
Tivey AR, Van AS, Walker D, Wanless D, Wang S, White B, White O, Whitehead S,
Woodward J, Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD, Fairlamb AH,
Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser CM, Melville SE, El-Sayed NM (2005)
The genome of the African trypanosome Trypanosoma brucei. Science 309:416-422
Black S, Seed J (2001) World class parasites: volume 1 the African trypanosomes. Kluwer
Academic Publishers, Boston, MA
Breidbach T, Ngazoa E, Steverding D (2002) Trypanosoma brucei: in vitro slender-to-stumpy
differentiation of culture-adapted, monomorphic bloodstream forms. Exp Parasitol 101:
223-230
Broadhead R, Dawe HR, Farr H, Griffiths S, Hart SR, Portman N, Shaw MK, Ginger ML,
Gaskell SJ, McKean PG, Gull K (2006) Flagellar motility is required for the viability of the
bloodstream trypanosome. Nature 440:224-227
Brun R, Blum J, Chappuis F, Burri C (2010) Human African trypanosomiasis. Lancet 375(9709):
148-159
Butler D (2007) Lost in translation. Nature 449:158-159
Castro JA, de Mecca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas'
disease (American trypanosomiasis). Hum Exp Toxicol 25:471-479
Chirac P, Torreele E (2006) Global framework on essential health R&D. Lancet 367:1560-1561
Cohen J (2006) Global health. Public-private partnerships proliferate. Science 311:167
Croft SL, Coombs GH (2003) Leishmaniasis-current chemotherapy and recent advances in the
search for novel drugs. Trends Parasitol 19:502-508
D'Angelo MA, Sanguineti S, Reece JM, Birnbaumer L, Torres HN, Flawia MM (2004) Iden-
tification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific
phosphodiesterase from Trypanosoma cruzi. Biochem J 378:63-72
De Koning HP (2008) Ever-increasing complexities of diamidine and arsenical crossresistance
in African trypanosomes. Trends Parasitol 24:345-349
Delespaux V, De Koning HP (2007) Drugs and drug resistance in African trypanosomiasis.
Drug Resist Updat 10:30-50
Diaz-Benjumea R, Laxman S, Hinds TR, Beavo JA, Rascon A (2006) Characterization of a novel
cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypa-
nosoma cruzi. Biochem J 399:305-314
Farrell J (2002) World class parasites: volume 4 Leishmania. Kluwer Academic Publishers, Boston
Gong KW, Kunz S, Zoraghi R, Kunz RC, Brun R, Seebeck T (2001) cAMP-specific phosphodies-
terase TbPDE1 is not essential in Trypanosoma brucei in culture or during midgut infection of
tsetse flies. Mol Biochem Parasitol 116:229-232
Gould MK, Vu XL, Seebeck T, De Koning HP (2008) Propidium iodide-based methods for
monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay. Anal
Biochem 382:87-93
Huai Q, Liu Y, Francis SH, Corbin JD, Ke H (2004) Crystal structures of phosphodiesterases 4
and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation deter-
minant of inhibitor selectivity. J Biol Chem 279:13095-13101
Huang H, Werner C, Weiss LM, Wittner M, Orr GA (2002) Molecular cloning and expression of
the catalytic subunit of protein kinase A from Trypanosoma cruzi. Int J Parasitol 32:1107-1115
Huang H, Weiss LM, Nagajyothi F, Tanowitz HB, Wittner M, Orr GA, Bao Y (2006) Molecular
cloning and characterization of the protein kinase A regulatory subunit of Trypanosoma cruzi.
Mol Biochem Parasitol 149:242-245
Hunger-Glaser I, Seebeck T (1997) Deletion of the genes for the paraflagellar rod protein PFR-A in
Trypanosoma brucei is probably lethal. Mol Biochem Parasitol 90:347-351
Ivey FD, Wang L, Demirbas D, Allain C, Hoffman CS (2008) Development of a fission yeast-
based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases.
J Biomol Screen 13:62-71
